News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
信達生物(01801.HK)升逾6% 首錄全年盈利賺8.14億人幣
信達生物(01801.HK)實現首次全年盈利，刺激股價今日(27日)高開0.88%後升幅擴大，最高見85.55元。現報84.7元，升6.68%，成交1,069.8萬股，涉資8.9億元。信達生物(01801.HK)去年虧轉盈賺8.14億元人民幣(下同)，營業額130.42億元人民幣，按年升38.4%。按非國際財務報告準則計量，利潤達17.23億元。公司產品組合...
Reset
Send
The window will close in 5 seconds
信達生物(01801.HK)升逾6% 首錄全年盈利賺8.14億人幣
Close
Recommend
1
Positive
5
Negative
4
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get NVDA share!

信達生物(01801.HK)  +0.600 (+0.660%)    Short selling $398.18M; Ratio 95.618%   實現首次全年盈利，刺激股價今日(27日)高開0.88%後升幅擴大，最高見85.55元。現報84.7元，升6.68%，成交1,069.8萬股，涉資8.9億元。

信達生物(01801.HK)  +0.600 (+0.660%)    Short selling $398.18M; Ratio 95.618%   去年虧轉盈賺8.14億元人民幣(下同)，營業額130.42億元人民幣，按年升38.4%。按非國際財務報告準則計量，利潤達17.23億元。

公司產品組合擴大至18款上市產品，其中12款產品已納入中國國家醫保藥品目錄。三項核心創新資產已進入或即將進入全球III期臨床研究，其目標市場規模合計超過600億美元。(mn/a)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-02 16:25.)

AASTOCKS新聞

Switch to Auto-Translated Version
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.